Published in Circulation on August 01, 1995
Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome (CLIMA) | NCT02883088
Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve. JACC Cardiovasc Imaging (2015) 4.28
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest (1996) 3.64
The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol (2010) 3.29
In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest (1998) 3.17
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest (2005) 2.44
Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A (1999) 2.33
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging (2009) 2.17
Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15
Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol (2013) 1.93
Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab (2009) 1.85
Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation (2009) 1.84
Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol (2007) 1.82
MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol (2010) 1.78
Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov (2011) 1.78
Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) (2008) 1.77
KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med (2015) 1.75
In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy. Atherosclerosis (2005) 1.72
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol (1996) 1.66
Characterization of atherosclerotic plaques by laser speckle imaging. Circulation (2005) 1.66
Iodinated contrast opacification gradients in normal coronary arteries imaged with prospectively ECG-gated single heart beat 320-detector row computed tomography. Circ Cardiovasc Imaging (2009) 1.64
Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther (2003) 1.61
Development of a catheter for combined intravascular ultrasound and photoacoustic imaging. Rev Sci Instrum (2010) 1.61
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging (2008) 1.52
The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med (2008) 1.51
Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site. Thromb Haemost (2009) 1.51
In-vivo, cardiac-cycle related intimal displacement of coronary plaques assessed by 3-D ECG-gated intravascular ultrasound: exploring its correlate with tissue deformability identified by palpography. Int J Cardiovasc Imaging (2005) 1.49
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med (2006) 1.48
Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus. J Am Chem Soc (2011) 1.47
Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol (2009) 1.44
Intravascular optical imaging technology for investigating the coronary artery. JACC Cardiovasc Imaging (2011) 1.42
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology. Int J Cardiovasc Imaging (2005) 1.42
Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr (2017) 1.39
Retracted Sagunja-Tang Improves Lipid Related Disease in a Postmenopausal Rat Model and HepG2 Cells. Evid Based Complement Alternat Med (2015) 1.39
Retracted Prognostic utility of coronary computed tomographic angiography: a 5-year follow-up in type 2 diabetes patients with suspected coronary artery disease. J Diabetes Res (2014) 1.38
Effects of intima stiffness and plaque morphology on peak cap stress. Biomed Eng Online (2011) 1.36
Measurement of fibrous cap thickness in atherosclerotic plaques by spatiotemporal analysis of laser speckle images. J Biomed Opt (2006) 1.36
Intravascular laser speckle imaging catheter for the mechanical evaluation of the arterial wall. J Biomed Opt (2011) 1.35
MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol (2008) 1.32
High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 1.30
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res (2012) 1.29
Laguerre-based method for analysis of time-resolved fluorescence data: application to in-vivo characterization and diagnosis of atherosclerotic lesions. J Biomed Opt (2006) 1.29
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A (1999) 1.28
Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med (2006) 1.27
Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries. Heart (2001) 1.25
Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutr J (2012) 1.23
Athero-express: differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design. Eur J Epidemiol (2004) 1.23
Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging. J Lipid Res (2011) 1.19
Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA (2014) 1.17
3D MRI-based anisotropic FSI models with cyclic bending for human coronary atherosclerotic plaque mechanical analysis. J Biomech Eng (2009) 1.17
Intracranial atherosclerosis: incidence, diagnosis and treatment. J Clin Neurol (2005) 1.16
MRI detects increased coronary wall thickness in asymptomatic individuals: the multi-ethnic study of atherosclerosis (MESA). J Magn Reson Imaging (2008) 1.15
Heme on innate immunity and inflammation. Front Pharmacol (2014) 1.15
Bacteria present in carotid arterial plaques are found as biofilm deposits which may contribute to enhanced risk of plaque rupture. MBio (2014) 1.14
Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J (2009) 1.14
The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol (2013) 1.10
ARFI imaging for noninvasive material characterization of atherosclerosis. Part II: toward in vivo characterization. Ultrasound Med Biol (2008) 1.08
The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions? Cell Stress Chaperones (2009) 1.08
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
Imaging of the unstable plaque: how far have we got? Eur Heart J (2009) 1.06
Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart (2007) 1.04
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease. Front Physiol (2014) 1.03
Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9. J Clin Neurol (2011) 1.03
EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.02
Accuracy of dual-source CT in the characterisation of non-calcified plaque: use of a colour-coded analysis compared with virtual histology intravascular ultrasound. Br J Radiol (2009) 1.02
Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease. J Med Genet (2006) 1.02
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population. Curr Atheroscler Rep (2011) 1.02
Association between increased epicardial adipose tissue volume and coronary plaque composition. Heart Vessels (2013) 1.02
The assessment of the vulnerable atherosclerotic plaque using MR imaging: a brief review. Int J Cardiovasc Imaging (2001) 1.01
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol (2009) 1.01
Vascular ultrasound for atherosclerosis imaging. Interface Focus (2011) 1.00
Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging (2009) 1.00
Flow-dependent cellular mechanotransduction in atherosclerosis. J Cell Sci (2013) 1.00
Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro. Int J Cardiovasc Imaging (2010) 1.00
Imaging of coronary atherosclerosis - evolution towards new treatment strategies. Nat Rev Cardiol (2016) 0.99
Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy. Pol Arch Med Wewn (2010) 0.99
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A (2012) 0.99
Inflammation and plaque vulnerability. J Intern Med (2015) 0.99
Evaluating the viscoelastic properties of tissue from laser speckle fluctuations. Sci Rep (2012) 0.99
Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol (2005) 0.98
18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging (2006) 0.97
Advanced contour detection for three-dimensional intracoronary ultrasound: a validation--in vitro and in vivo. Int J Cardiovasc Imaging (2002) 0.95
Empirical and theoretical phenotypic discrimination. J Thromb Haemost (2009) 0.95
Characterization of coronary atherosclerosis by dual-source computed tomography and HU-based color mapping: a pilot study. Eur Radiol (2008) 0.94
Effect of statin therapy on the progression of coronary atherosclerosis. BMC Cardiovasc Disord (2012) 0.94
Caveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease. PLoS One (2008) 0.94
Thermal strain imaging: a review. Interface Focus (2011) 0.94
Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv (2016) 0.94
10-years experience with the Athero-Express study. Cardiovasc Diagn Ther (2012) 0.93
Coronary artery calcium scoring, what is answered and what questions remain. Cardiovasc Diagn Ther (2012) 0.93
Inflammatory biomarkers in atherosclerosis: pentraxin 3 can become a novel marker of plaque vulnerability. PLoS One (2014) 0.93
Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 0.93
Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats. PLoS One (2012) 0.93
Radiolabelled probes for imaging of atherosclerotic plaques. Am J Nucl Med Mol Imaging (2012) 0.93
Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis. Circ Res (2016) 0.92
Photoacoustic imaging of human coronary atherosclerosis in two spectral bands. Photoacoustics (2013) 0.92
Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. Vasc Health Risk Manag (2008) 0.91
Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation (2003) 3.45
Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation (1996) 3.34
Restrictive cardiomyopathy. N Engl J Med (1997) 3.29
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation (2001) 2.56
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest (1990) 2.55
Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation (1996) 2.46
The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol (1981) 2.44
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41
Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res (2001) 2.35
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol (1984) 2.08
Low-dose aspirin and stroke. "It ain't necessarily so". Stroke (1992) 2.04
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.01
Management of stable coronary artery disease. Am Fam Physician (1997) 1.97
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation (1999) 1.94
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1996) 1.94
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (1999) 1.92
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol (2000) 1.73
Glomerular coagulation in acute ischaemic renal failure. Q J Med (1970) 1.73
Coronary thrombolysis--a perspective for the practicing physician. N Engl J Med (1993) 1.72
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation (2000) 1.70
Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol (1985) 1.68
Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation (1997) 1.67
How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) Am J Cardiol (1995) 1.53
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up. J Am Coll Cardiol (2001) 1.51
Reproductive history in women with coronary heart disease. A case-control study. Am J Epidemiol (1984) 1.50
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Angiographic patterns of balloon inflation during percutaneous transluminal coronary angioplasty: role of pressure-diameter curves in studying distensibility and elasticity of the stenotic lesion and the mechanism of dilation. J Am Coll Cardiol (1990) 1.49
Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation (2000) 1.49
Refractory prinzmetal angina treated with cyproheptadine. Ann Intern Med (1994) 1.48
Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol (1985) 1.46
Atrial fibrillation--risk marker for stroke. N Engl J Med (1990) 1.46
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol (1983) 1.45
Inhibition of acute stent thrombosis under high-shear flow conditions by a nitric oxide donor, DMHD/NO. An ex vivo porcine arteriovenous shunt study. Circulation (1996) 1.44
ST elevations in leads V1 to V5 may be caused by right coronary artery occlusion and acute right ventricular infarction. Am J Cardiol (1984) 1.42
Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol (1996) 1.42
AHA's new strategic impact goal designed to curb epidemic of cardiovascular disease and stroke. Circulation (1999) 1.42
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res (1985) 1.42
The editor's roundtable: atherosclerosis regression. Am J Cardiol (2008) 1.42
Assay of platelet factor 4 in plasma. Mayo Clin Proc (1973) 1.41
Intracardiac thrombi and systemic embolization. Ann Intern Med (1986) 1.41
Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation (1987) 1.40
Lipid lowering versus revascularization: an idea whose time (for testing) has come. Circulation (1997) 1.40
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
Coronary excimer laser angioplasty: reduced complications and indium-111 platelet accumulation compared with thermal laser angioplasty. J Am Coll Cardiol (1990) 1.39
A human immunodeficiency virus-resistant airway for cardiopulmonary resuscitation. Am J Emerg Med (1992) 1.38
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol (1994) 1.37
Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36
Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation (1998) 1.36
Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase. Am J Cardiol (1987) 1.36
Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation (2001) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation (1992) 1.34
Arteriographic patterns early in the onset of the coronary syndromes. Br Heart J (1975) 1.32
Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve. Mayo Clin Proc (1979) 1.30
Aspirin in the prevention of coronary disease. N Engl J Med (1989) 1.30
Neovascularization in human atherosclerosis. Curr Mol Med (2006) 1.30
Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation (1999) 1.28
Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1997) 1.28
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation (1994) 1.26
T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.26
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest (1989) 1.26
The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med (1992) 1.25
Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? Circulation (2001) 1.25
Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol (1992) 1.24